Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Gvhd Prophylaxis With Mycophenolate Mofetil and Calcineurin Inhibitor In Allogeneic Hematopoietic Cell Transplantation From HLA-Matched Siblings Or 7–8/8 HLA-Matched Unrelated Volunteer Donors: A Japanese, Multicenter, Phase II Trial

Takahiko Nakane, M.D., Ph.D., Hirohisa Nakamae, MD, PhD, Saiko Kurosawa, MD, Atsuo Okamura, MD, PhD, Michihiro Hidaka, MD, PhD, Takuya Yamashita, MD, PhD, Akio Kohno, MD, PhD, Takeshi Saito, MD, Yasutaka Aoyama, MD, PhD, Kazuo Hatanaka, MD, Yoshio Katayama, MD, PhD, Kimikazu Yakushijin, MD, PhD, Toshimitsu Matsui, MD, PhD, Akiyoshi Takami, MD, PhD, Takuhiro Yamaguchi, PhD, Masayuki Hino, MD, PhD, Takahiro Fukuda, MD

Blood (2013) 122 (21): 4586.

https://doi.org/10.1182/blood.V122.21.4586.4586

Published: 2013

Journal Articles

A New Strategy Of MDS Treatment With Azacitidine (AZA): Induction With AZA Combined With Low Dose AraC Followed By Maintenance Therapy With AZA

Manabu Hirai, MD, PHD, Takahiko Nakane, M.D., Ph.D., Atsushi Inoue, MD, Mitsuharu Hashimura, MD, Mizuki Aimoto, M.D., Erina Sakamoto, MD, PHD, Hirohisa Nakamae, MD, PhD, Masayuki Hino, MD, PhD

Blood (2013) 122 (21): 1536.

https://doi.org/10.1182/blood.V122.21.1536.1536

Published: 2013

Journal Articles

HLA Haplo-Identical Peripheral Blood Stem Cell Transplantation Using High-Dose Cyclophosphamide Post-Transplantation For Poor Prognosis Or Refractory Acute Leukemia and Myelodysplastic Syndrome: A Prospective Pilot Study At a Single Center

Hirohisa Nakamae, MD, PhD, Hideo Koh, M.D., Ph.D., Mitsutaka Nishimoto, M.D., Ph.D., Yasuhiro Nakashima, M.D., Ph.D., Satoru Nanno, M.D., Takuro Yoshimura, M.D., Ph.D., Shiro Koh, M.D., Hiroshi Okamura, M.D., Jyoji Nagasaki, M.D., Takahiko Nakane, M.D., Ph.D., Mika Nakamae, M.D., Ph.D., Asao Hirose, M.D., Ph.D., Masayuki Hino, MD, PhD

Blood (2013) 122 (21): 3404.

https://doi.org/10.1182/blood.V122.21.3404.3404

Published: 2013

Journal Articles

Immunoprofile of Patients with Chronic Myeloid Leukemia Treated with Imatinib, Nilotinib or Dasatinib,

Yoshiki Hayashi, M.D., Hirohisa Nakamae, MD, PhD, Takako Katayama, Takahiko Nakane, M.D., Ph.D., Hideo Koh, M.D., Ph.D, Mitsutaka Nishimoto, M.D., Mika Nakamae, M.D., Ph.D, Masahiro Yoshida, M.D., Masato Bingo, M.D., Hiroshi Okamura, M.D., Mizuki Aimoto, M.D., Masahiro Manabe, M.D., Takuro Yoshimura, M.D., Akiko Inaba, M.D., Satoshi Nanno, M.D., Kiyoyuki Hagihara, M.D., Ph.D, Yoshitaka Nakao, M.D., Ph.D, Yoshiki Terada, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2011) 118 (21): 3764.

https://doi.org/10.1182/blood.V118.21.3764.3764

Published: 2011

Journal Articles

Risk Factors Affecting Cardiac Left Ventricular Systolic and Diastolic Function and Hypertrophy in the Chronic Phase Post-Allogeneic Hematopietic Cell Transplantation

Mitsutaka Nishimoto, M.D., Hirohisa Nakamae, MD, PhD, Takahiko Nakane, M.D., Ph.D., Hideo Koh, M.D., Ph.D, Yoshiki Hayashi, M.D., Mika Nakamae, M.D., Ph.D, Masahiro Yoshida, M.D., Masato Bingo, M.D., Hiroshi Okamura, M.D., Mizuki Aimoto, M.D., Masahiro Manabe, M.D., Takuro Yoshimura, M.D., Akiko Inaba, M.D., Satoshi Nanno, M.D., Asao Hirose, M.D., Ph.D., Kiyoyuki Hagihara, M.D., Ph.D, Yoshitaka Nakao, M.D., Ph.D, Yoshiki Terada, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2011) 118 (21): 2000.

https://doi.org/10.1182/blood.V118.21.2000.2000

Published: 2011

Journal Articles

Factors That Contribute to Long-Term Survival In Patients with Leukemia Not In Remission at Allogeneic Hematopoietic Cell Transplantation

Blood (2010) 116 (21): 3551.

https://doi.org/10.1182/blood.V116.21.3551.3551

Published: 2010

NARROW

Gvhd Prophylaxis With Mycophenolate Mofetil and Calcineurin Inhibitor In Allogeneic Hematopoietic Cell Transplantation From HLA-Matched Siblings Or 7–8/8 HLA-Matched Unrelated Volunteer Donors: A Japanese, Multicenter, Phase II Trial

A New Strategy Of MDS Treatment With Azacitidine (AZA): Induction With AZA Combined With Low Dose AraC Followed By Maintenance Therapy With AZA

HLA Haplo-Identical Peripheral Blood Stem Cell Transplantation Using High-Dose Cyclophosphamide Post-Transplantation For Poor Prognosis Or Refractory Acute Leukemia and Myelodysplastic Syndrome: A Prospective Pilot Study At a Single Center

Immunoprofile of Patients with Chronic Myeloid Leukemia Treated with Imatinib, Nilotinib or Dasatinib,

Risk Factors Affecting Cardiac Left Ventricular Systolic and Diastolic Function and Hypertrophy in the Chronic Phase Post-Allogeneic Hematopietic Cell Transplantation

Factors That Contribute to Long-Term Survival In Patients with Leukemia Not In Remission at Allogeneic Hematopoietic Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Gvhd Prophylaxis With Mycophenolate Mofetil and Calcineurin Inhibitor In Allogeneic Hematopoietic Cell Transplantation From HLA-Matched Siblings Or 7–8/8 HLA-Matched Unrelated Volunteer Donors: A Japanese, Multicenter, Phase II Trial

A New Strategy Of MDS Treatment With Azacitidine (AZA): Induction With AZA Combined With Low Dose AraC Followed By Maintenance Therapy With AZA

HLA Haplo-Identical Peripheral Blood Stem Cell Transplantation Using High-Dose Cyclophosphamide Post-Transplantation For Poor Prognosis Or Refractory Acute Leukemia and Myelodysplastic Syndrome: A Prospective Pilot Study At a Single Center

Immunoprofile of Patients with Chronic Myeloid Leukemia Treated with Imatinib, Nilotinib or Dasatinib,

Risk Factors Affecting Cardiac Left Ventricular Systolic and Diastolic Function and Hypertrophy in the Chronic Phase Post-Allogeneic Hematopietic Cell Transplantation

Factors That Contribute to Long-Term Survival In Patients with Leukemia Not In Remission at Allogeneic Hematopoietic Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only